ABSTRACT β-Lactams are the most widely prescribed antibiotics used for the control and
treatment of bacterial infections. The direct effect of β-lactams on bacteria is well studied …

Introduction Omadacycline is approved for the treatment of community-acquired bacterial
pneumonia (CABP) and acute bacterial skin and soft tissue infection (ABSSSI). The …

Background There are several antibiotic regimens to treat community-acquired pneumonia
(CAP). Research Question In patients hospitalized to a non-ICU ward setting with CAP, is …

Objectives Community-acquired pneumonia (CAP) is a significant source of hospital
admissions and mortality. Atypical organisms are implicated in up to 40% of cases of CAP …

Community-acquired pneumonia (CAP) is a common infectious syndrome in Australia and a
leading global cause of morbidity and mortality. It drives a significant amount of antimicrobial …

Background The 2017 Korean guideline on community-acquired pneumonia (CAP)
recommended beta-lactam plus macrolide combination therapy for patients hospitalized with …

Objective: Inappropriate antimicrobial use leads to drug resistance and poor clinical
outcomes. Considering the lack of data regarding the drug use patterns in the treatment of …

Background. Community acquired pneumonia (CAP) is a common serious infection that is
usually treated with a macrolide with a β‐lactam while doxycycline is considered an …

Community-acquired pneumonia is a common respiratory infection, with high morbidity and
mortality in adult patients. The difficulty in etiological diagnosis means that in most cases …

Background Acinetobacter baumannii (AB) is a Gram-negative pathogen associated with
high patient morbidity and mortality in nosocomial infections. Limited treatment options are …